Quick Answer
Insight Molecular Diagnostics Inc. reported Operating Income of -$51.12 million for fiscal year 2025.
Insight Molecular Diagnostics Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$51.12M | +16.2% |
| 2024 | -$61.04M | -142.8% |
| 2023 | -$25.14M | -39.7% |
| 2022 | -$18.00M | +66.5% |
| 2021 | -$53.73M | -80.8% |
| 2020 | -$29.71M | -33.6% |
| 2019 | -$22.24M | -46.3% |
| 2018 | -$15.20M | +19.3% |
| 2017 | -$18.85M | -69.2% |
| 2016 | -$11.14M | -27.8% |
| 2015 | -$8.72M | -75.3% |
| 2014 | -$4.97M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$11.05M | +18.3% | -12.3% |
| June 30, 2025 | -$9.84M | -112.5% | -44.8% |
| March 31, 2025 | -$6.80M | +26.6% | +49.7% |
| September 30, 2024 | -$13.52M | -107.5% | -191.8% |
| June 30, 2024 | -$4.63M | +44.2% | +50.0% |
| March 31, 2024 | -$9.27M | -258.4% | -42.3% |
| September 30, 2023 | -$6.51M | -281.8% | +21.5% |
| June 30, 2023 | -$8.29M | -410.1% | -241.8% |
- Insight Molecular Diagnostics Inc. showed an increase of +16.2% in Operating Income compared to the prior fiscal year.
- Over the 2014–2025 period, Insight Molecular Diagnostics Inc.’s operating income has declined by 928.0% (from -$4.97 million to -$51.12 million).
- The most recent figure is from Insight Molecular Diagnostics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: